Shire plc Shire Plc Director And Senior Management Changes

TIDMSHP 
 
 
   Shire plc Director and Senior Management Changes 
 
   August 21, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the 
"Company"), announces changes to its Executive Committee, as it 
progresses its strategy to sharpen its focus as a leader in rare 
diseases. 
 
   Jeff Poulton, Chief Financial Officer, will be leaving Shire at the end 
of the year to serve as CFO at Indigo Ag, Inc., a start-up company based 
in Boston that uses the plant microbiome to improve the productivity and 
sustainability of agriculture. The Board will commence a formal search 
for a successor and Jeff will continue to serve in his current role as 
this search progresses. During this transition period, Jeff will remain 
on the Executive Committee and on the Board of Directors of Shire plc. 
Jeff will also continue to support the Company's on-going strategic 
review of its business. 
 
   Dr. Flemming Ornskov, MD, MPH, Chief Executive Officer, said: "It is 
with regret that we announce Jeff's upcoming departure. Having held 
numerous roles within the Company, Jeff has demonstrated steadfast 
commitment to Shire through a very intense period of activity and has 
made significant contributions to our organization. Jeff will continue 
to lead the Shire Finance team through the Q3 reporting period and to 
the end of the year, and will play an active role in the search for his 
successor.  On behalf of all Shire employees, we are grateful to Jeff 
for his dedication and leadership and wish him the very best in his 
future endeavours." 
 
   Jeff Poulton, Chief Financial Officer, said: "It has been a privilege to 
work for Shire and to have played a part in the exceptional growth story 
of such an inspirational company. It has been a difficult decision, but 
in departing Shire, I wanted to join a smaller organization where I can 
play a role in building a new company.  As Shire finalizes the 
integration of Baxalta and focusses on paying down debt, this also 
presents a perfect time for me to begin this transition.  I know I leave 
Shire well positioned to pursue its strategy and deliver value for 
shareholders, supported by a strong Finance team." 
 
   Susan Kilsby, Chairman of the Board, said: "On behalf of the Board of 
Directors, I want to thank Jeff for his long tenure and unwavering 
dedication to Shire and our patients. While we will miss Jeff's positive 
spirit and professionalism, we understand his decision to start a new 
career. During Jeff's time at Shire he has travelled the globe, 
transformed the Finance department, and led the continued successful 
integration of Baxalta and many other acquisitions. We fully appreciate 
his contributions that have helped to make Shire a great organization." 
 
   This notification is to satisfy the Company's obligations under LR 
9.6.11R of the UK Listing Rules. 
 
   The Company also announces that Joanne Cordeiro has been appointed Chief 
Human Resources Officer and a member of the Executive Committee, 
effective immediately. Joanne takes over the role held by Ginger 
Gregory.  Joanne joined Shire in March 2011 and has been serving as 
Interim Head of Human Resources since March 2017. Before joining Shire, 
Joanne served in various Human Resources management and executive search 
roles at Teradyne Inc., Covansys Corporation (now a DXC Technology 
Company), Avid Technology, Inc., and Sybase Inc. (now an SAP company). 
 
   In reference to Joanne's appointment, Dr. Ornskov said: "I have worked 
closely with Joanne over the past several years as we have transformed 
Shire into the global leader in the treatment of rare diseases. Joanne's 
dedication, skill, and expertise have been an invaluable resource in the 
successful integration of Baxalta into the Shire business.  She is a 
trusted partner to the entire management team and a passionate supporter 
of our in-house talent and leadership development programs, which are 
crucial to our business." 
 
   Joanne Cordeiro, Chief Human Resources Officer, said: "It is an honor to 
accept this appointment and I look forward to the opportunity to 
continue building on the expertise and passion of my colleagues at Shire, 
attracting top talent to our organization, and working with the rest of 
the Executive Committee, all of whom are dedicated to improving the 
lives of the patients we serve." 
 
   For further information please contact: 
 
 
 
 
Investor Relations 
Ian Karp             ikarp@shire.com        +1 781 482 9018 
Robert Coates        rcoates@shire.com      +44 1256 894874 
Media 
Lisa Adler           lisa.adler@shire.com   +1 617 588 8607 
Debbi Ford           debbi.ford@shire.com   +1 617 949 9083 
 
 
   For information regarding Indigo Ag, Inc., please contact: 
 
 
 
 
Lauren Ashbrook   lashbrook@indigoag.com   + 1 617 909-9390 
 
 
   NOTES TO EDITORS 
 
   Stephen Williams, Deputy Company Secretary, is responsible for arranging 
the release of this announcement. 
 
   Inside Information 
 
   This announcement contains inside information. 
 
   Remuneration 
 
   Jeff Poulton will continue to be paid in line with his current 
remuneration arrangements until his date of departure. Details of the 
remuneration arrangements relating to Mr. Poulton's departure will be 
disclosed in due course. 
 
   About Shire 
 
   Shire is the leading global biotechnology company focused on serving 
people with rare diseases. We strive to develop best-in-class products, 
many of which are available in more than 100 countries, across core 
therapeutic areas including Hematology, Immunology, Neuroscience, 
Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal 
Medicine / Endocrine and Hereditary Angioedema; and a growing franchise 
in Oncology. 
 
   Our employees come to work every day with a shared mission: to develop 
and deliver breakthrough therapies for the hundreds of millions of 
people in the world affected by rare diseases and other high-need 
conditions, and who lack effective therapies to live their lives to the 
fullest. 
 
   www.shire.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Shire plc via Globenewswire
(END) Dow Jones Newswires
August 21, 2017 09:15 ET (13:15 GMT)
Shire Plc ADS, Each Representing Three Ordinary Shares (NASDAQ:SHPG)
Historical Stock Chart
From Apr 2024 to May 2024